Hexarelin
Also known as: Examorelin, HEX
Primary recreational use: Growth hormone release and muscle growth.
What is Hexarelin?
Hexarelin, also known as Examorelin, is a synthetic hexapeptide growth hormone-releasing peptide developed by Mediolanum Farmaceutici. Originally explored for treating growth hormone deficiency and heart conditions, it is now primarily used for its potent growth hormone release and cardioprotective properties. Although promising in clinical trials, Hexarelin is not FDA approved due to strategic discontinuation. Users should note potential desensitization and elevations in cortisol and prolactin levels.
Primary Benefits
Promotes growth hormone release. Offers cardioprotective effects. Enhances tissue repair and recovery.
How It Works
Hexarelin works by binding to the ghrelin receptor (GHSR-1a) on pituitary somatotrophs, inducing potent growth hormone release. It also uniquely binds to CD36 receptors in cardiac tissue, providing cardioprotective effects through anti-apoptotic and anti-fibrotic mechanisms.
Safety Tips
Precautions reported in community discussions and literature. This is not a complete list.
- 1.DON'T start with high doses; begin with the lowest effective dose to assess tolerance.
- 2.AVOID continuous use without breaks to manage desensitization.
- 3.NEVER inject after meals; administer in a fasted state for optimal results.
- 4.DON'T store reconstituted solution outside the refrigerator.
- 5.DON'T use if prone to cortisol or prolactin elevation-related issues.
- 6.AVOID combining with GH or IGF-1 administration due to blunted effects.
- 7.DON'T use if you have a history of active cancer due to growth-promoting effects.
- 8.NEVER share needles or vials to prevent infections.
Use Contexts
Different purposes have different protocols, dosing, and considerations
Growth hormone deficiency and congestive heart failure
strong evidenceHexarelin has shown potential in clinical trials for treating growth hormone deficiency and providing cardioprotection in heart failure patients. However, development was halted for strategic reasons despite these promising effects.
Evidence: Clinical trials and studies have shown dose-dependent GH release and cardioprotective effects.
The following are ranges reported in published literature and community discussions. These are NOT recommendations or medical advice.
Timing: Administer on an empty stomach, morning and evening
Notes: Cycling off every 4-6 weeks is recommended to prevent desensitization.
Community-Reported Protocols
Not recommendations: The following protocols are compiled from online communities and published literature. Pepbase does not endorse, recommend, or verify these protocols. They are provided for informational purposes only. Individual responses vary significantly. Consult a licensed medical professional before any use.
| Reported Goal | Reported Dose | Reported Frequency | Reported Route |
|---|---|---|---|
| Growth hormone optimization | 100 mcg | 3x daily | Subcutaneous injection |
| Cardioprotection | 100-200 mcg | 2x daily | Subcutaneous injection |
Pharmacokinetics
Reported Side Effects
This is not a complete list. Other side effects may occur.
Common
Serious / Rare
- Secondary hypogonadism due to elevated prolactin
- Cardiac abnormalities in individuals with existing conditions
Injection-Specific Warnings
- Injection site reactions possible; rotate sites to minimize risks.
Storage
Harm Reduction Information
Quality Concerns
- Potentially impure products from unverified sources
- Degradation if not properly stored
Safety Tips
- Use only sterile water for reconstitution and inject subcutaneously.
- Rotate injection sites to avoid irritation.
- Store in a refrigerator and keep away from light.
Warning Signs to Stop
- Severe water retention
- High blood pressure
- Acute headache
Seek Medical Help Immediately If
- Signs of severe cardiac distress
- New onset of diabetes or glucose intolerance
Frequently Asked Questions
Common questions about Hexarelin
How long until I see effects?
With Hexarelin, growth hormone release peaks around 30 minutes after injection, but changes in body composition may take 4-8 weeks to manifest.
What time of day should I take it?
Hexarelin should be taken in the morning and before bed in a fasted state to maximize growth hormone pulses.
How can I minimize side effects?
To minimize side effects with Hexarelin, adhere to recommended cycling protocols and monitor any elevations in cortisol and prolactin.
Does tolerance develop?
Yes, partial desensitization to Hexarelin occurs with prolonged use, necessitating off-cycles to restore efficacy.
How should I store it?
Hexarelin should be stored in a refrigerator at 2-8°C, especially after reconstitution, and used within 4 weeks.
Do I need to cycle it?
Cycling is crucial with Hexarelin. A typical cycle involves 8-16 weeks of use followed by a 4-6 week break.
Reported Combinations
Compounds reported to be used alongside Hexarelin in community discussions
CJC-1295
Combined use with Hexarelin can enhance pulsatile GH release.
Ipamorelin
Less desensitization compared to other GHRPs, complements Hexarelin's effects.
Exercise
Exercise can enhance GH pulses naturally and improve outcomes.
Sermorelin
Synergistic in enhancing GH release when combined.
Reported Interactions
Interactions reported in literature and community discussions.
May increase jitteriness when combined with GH release.
May counteract heart-related benefits of Hexarelin.
Similar pathway activation can lead to excessive prolactin.
Monitor for potential hypotensive effects.
Safe but may affect sleep quality when taken with GH secretagogues.
Reconstitution Calculator
100 units = 1 mL
Safety Tips
- Always consult a licensed medical professional for dosing and reconstitution instructions.
- Always double check your units. Mixing up mg and mcg can be very dangerous.
- Make sure to select your syringe type. U-100 and U-50 syringes have different units.
- Ensure you're not adding more BAC than your vial can hold. Most vials have maximum capacities listed.
This calculator is for informational and educational purposes only. It does not provide medical advice, dosing recommendations, or safety determinations. Reference ranges shown are compiled from publicly available sources and are not a substitute for guidance from a licensed healthcare professional.
Legal Status by Region
Regulatory status varies by country
USA
investigational
UK
investigational
EU
investigational
Australia
investigational
Canada
investigational
Explore More Research
Browse our database of peptide research information compiled from published literature and community sources.
Citations
Last updated: October 6, 2023